JPS62292721A - 細菌感染症治療剤 - Google Patents
細菌感染症治療剤Info
- Publication number
- JPS62292721A JPS62292721A JP62140717A JP14071787A JPS62292721A JP S62292721 A JPS62292721 A JP S62292721A JP 62140717 A JP62140717 A JP 62140717A JP 14071787 A JP14071787 A JP 14071787A JP S62292721 A JPS62292721 A JP S62292721A
- Authority
- JP
- Japan
- Prior art keywords
- tables
- formulas
- coli
- index
- mathematical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000894006 Bacteria Species 0.000 title description 7
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002195 synergetic effect Effects 0.000 claims description 126
- 230000000996 additive effect Effects 0.000 claims description 64
- 239000000654 additive Substances 0.000 claims description 63
- 229940124587 cephalosporin Drugs 0.000 claims description 34
- 229930186147 Cephalosporin Natural products 0.000 claims description 31
- -1 methoxy, vinyl Chemical group 0.000 claims description 30
- 150000001780 cephalosporins Chemical class 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 27
- 239000000126 substance Substances 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 13
- 150000002148 esters Chemical class 0.000 claims description 13
- 229940124597 therapeutic agent Drugs 0.000 claims description 13
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims description 9
- HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 claims description 9
- 230000003115 biocidal effect Effects 0.000 claims description 8
- 208000035143 Bacterial infection Diseases 0.000 claims description 7
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 150000001768 cations Chemical class 0.000 claims description 5
- 125000004185 ester group Chemical group 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 229940127557 pharmaceutical product Drugs 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 241000588724 Escherichia coli Species 0.000 description 66
- 230000003993 interaction Effects 0.000 description 64
- 241000588923 Citrobacter Species 0.000 description 57
- 230000002401 inhibitory effect Effects 0.000 description 45
- 229910052708 sodium Inorganic materials 0.000 description 42
- 239000011734 sodium Substances 0.000 description 42
- 230000001580 bacterial effect Effects 0.000 description 35
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 31
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 22
- 230000005764 inhibitory process Effects 0.000 description 17
- FYZUENZXIZCLAZ-UHFFFAOYSA-N 2-methylhept-2-enoic acid Chemical compound CCCCC=C(C)C(O)=O FYZUENZXIZCLAZ-UHFFFAOYSA-N 0.000 description 12
- 229960004261 cefotaxime Drugs 0.000 description 11
- DKOQGJHPHLTOJR-WHRDSVKCSA-N cefpirome Chemical compound N([C@@H]1C(N2C(=C(C[N+]=3C=4CCCC=4C=CC=3)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 DKOQGJHPHLTOJR-WHRDSVKCSA-N 0.000 description 11
- 229960000466 cefpirome Drugs 0.000 description 11
- 229910052700 potassium Inorganic materials 0.000 description 11
- 239000011591 potassium Substances 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 10
- 159000000000 sodium salts Chemical class 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 8
- 244000052769 pathogen Species 0.000 description 8
- 229940088710 antibiotic agent Drugs 0.000 description 7
- QYQDKDWGWDOFFU-IUODEOHRSA-N Cefotiam Chemical compound CN(C)CCN1N=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CC=3N=C(N)SC=3)[C@H]2SC1 QYQDKDWGWDOFFU-IUODEOHRSA-N 0.000 description 6
- 229960001242 cefotiam Drugs 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- ZIHYVLFLVDRNED-UHFFFAOYSA-M sodium;2-methylhept-2-enoate Chemical compound [Na+].CCCCC=C(C)C([O-])=O ZIHYVLFLVDRNED-UHFFFAOYSA-M 0.000 description 4
- FVUCWGGFZNLYLD-UHFFFAOYSA-M [Na+].C(C=CCCCC)C(=O)[O-] Chemical compound [Na+].C(C=CCCCC)C(=O)[O-] FVUCWGGFZNLYLD-UHFFFAOYSA-M 0.000 description 3
- 229960004755 ceftriaxone Drugs 0.000 description 3
- 238000007911 parenteral administration Methods 0.000 description 3
- 150000002961 penems Chemical class 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- VAAUVRVFOQPIGI-SPQHTLEESA-N ceftriaxone Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C(=O)NN1C VAAUVRVFOQPIGI-SPQHTLEESA-N 0.000 description 2
- 239000013066 combination product Substances 0.000 description 2
- 229940127555 combination product Drugs 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- MVTIDDWEBUVRRW-XIDCRBKBSA-N (5r,6s)-3-(4-carbamoylphenoxy)-6-[(1r)-1-hydroxyethyl]-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid Chemical compound S([C@@H]1[C@H](C(N1C=1C(O)=O)=O)[C@H](O)C)C=1OC1=CC=C(C(N)=O)C=C1 MVTIDDWEBUVRRW-XIDCRBKBSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- OTTZHAVKAVGASB-UHFFFAOYSA-N 2-heptene Natural products CCCCC=CC OTTZHAVKAVGASB-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- 241000510930 Brachyspira pilosicoli Species 0.000 description 1
- 101100496854 Caenorhabditis elegans col-12 gene Proteins 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 241000588919 Citrobacter freundii Species 0.000 description 1
- 241001492658 Cyanea koolauensis Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 101150079116 MT-CO1 gene Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- VHCQVGQULWFQTM-UHFFFAOYSA-N Rubone Natural products COC1=CC(OC)=CC(O)=C1C(=O)C=CC1=CC(OC)=C(OC)C=C1OC VHCQVGQULWFQTM-UHFFFAOYSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000005042 acyloxymethyl group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 description 1
- 229950003476 aminothiazole Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Natural products CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 1
- 229960002129 cefixime Drugs 0.000 description 1
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 1
- XDZKBRJLTGRPSS-BGZQYGJUSA-N cefodizime Chemical compound S([C@@H]1[C@@H](C(N1C=1C(O)=O)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(C)=C(CC(O)=O)S1 XDZKBRJLTGRPSS-BGZQYGJUSA-N 0.000 description 1
- 229960001958 cefodizime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229960000479 ceftriaxone sodium Drugs 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- FDRNWTJTHBSPMW-GNXCPKRQSA-L disodium;(6r,7r)-7-[[(2e)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(2-methyl-6-oxido-5-oxo-1,2,4-triazin-3-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical class [Na+].[Na+].S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)/C(=N/OC)C=2N=C(N)SC=2)CC=1CSC1=NC(=O)C([O-])=NN1C FDRNWTJTHBSPMW-GNXCPKRQSA-L 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 244000000059 gram-positive pathogen Species 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002357 osmotic agent Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- FYQBQWCKCPLPFC-UHFFFAOYSA-M potassium;2-methylhept-2-enoate Chemical compound [K+].CCCCC=C(C)C([O-])=O FYQBQWCKCPLPFC-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000008227 sterile water for injection Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cephalosporin Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19863618813 DE3618813A1 (de) | 1986-06-04 | 1986-06-04 | Pharmazeutische zubereitung zur behandlung bakterieller infektionen |
| DE3618813.1 | 1986-06-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS62292721A true JPS62292721A (ja) | 1987-12-19 |
Family
ID=6302277
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62140717A Pending JPS62292721A (ja) | 1986-06-04 | 1987-06-04 | 細菌感染症治療剤 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4919932A (pt) |
| EP (1) | EP0248361B1 (pt) |
| JP (1) | JPS62292721A (pt) |
| CN (1) | CN87104023A (pt) |
| AR (1) | AR241305A1 (pt) |
| AT (1) | ATE71299T1 (pt) |
| AU (1) | AU597068B2 (pt) |
| CA (1) | CA1294217C (pt) |
| DD (1) | DD257015A5 (pt) |
| DE (2) | DE3618813A1 (pt) |
| DK (1) | DK166759B1 (pt) |
| EG (1) | EG18213A (pt) |
| ES (1) | ES2035829T3 (pt) |
| FI (1) | FI872459A (pt) |
| GR (1) | GR3003856T3 (pt) |
| HU (1) | HU199288B (pt) |
| IL (1) | IL82767A (pt) |
| MA (1) | MA20994A1 (pt) |
| MY (1) | MY101079A (pt) |
| NO (1) | NO872331L (pt) |
| NZ (1) | NZ220509A (pt) |
| OA (1) | OA08609A (pt) |
| PH (1) | PH26214A (pt) |
| PL (1) | PL266058A1 (pt) |
| PT (1) | PT84996B (pt) |
| TN (1) | TNSN87077A1 (pt) |
| ZA (1) | ZA873970B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1231487B (it) * | 1988-10-24 | 1991-12-07 | Erba Carlo Spa | Composizione sinergica antibatterica contenente penem e ceftizoximaf |
| DE69019395D1 (de) * | 1989-02-21 | 1995-06-22 | Banyu Pharma Co Ltd | Zusammensetzung gegen Mikroben. |
| DE3909056A1 (de) * | 1989-03-18 | 1990-09-20 | Hoechst Ag | Pharmazeutische kombinationspraeparate und deren verwendung zur prophylaxe oder behandlung bakterieller infektionskrankheiten |
| US7491263B2 (en) * | 2004-04-05 | 2009-02-17 | Technology Innovation, Llc | Storage assembly |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54126735A (en) * | 1978-03-24 | 1979-10-02 | Toyama Chem Co Ltd | Bactericidal composition for medical use |
| EP0041768B1 (en) * | 1980-04-24 | 1987-11-11 | Beecham Group Plc | Beta-lactam compounds, their preparation and use |
| ES8305366A1 (es) * | 1981-07-08 | 1983-04-01 | Hoechst Uk Ltd | "procedimiento para la preparacion de derivados de penem". |
| EP0120613A1 (en) * | 1983-03-02 | 1984-10-03 | Beecham Group Plc | Penem derivatives and precursors |
| DE3424144A1 (de) * | 1984-06-30 | 1986-01-09 | Bayer Ag, 5090 Leverkusen | Verfahren zur erhoehung der bruchfestigkeit von granalien |
-
1986
- 1986-06-04 DE DE19863618813 patent/DE3618813A1/de not_active Withdrawn
-
1987
- 1987-05-29 DE DE8787107803T patent/DE3775823D1/de not_active Expired - Fee Related
- 1987-05-29 ES ES198787107803T patent/ES2035829T3/es not_active Expired - Lifetime
- 1987-05-29 AT AT87107803T patent/ATE71299T1/de active
- 1987-05-29 EP EP87107803A patent/EP0248361B1/de not_active Expired - Lifetime
- 1987-06-02 AR AR87307752A patent/AR241305A1/es active
- 1987-06-02 MA MA21233A patent/MA20994A1/fr unknown
- 1987-06-02 PH PH35336A patent/PH26214A/en unknown
- 1987-06-02 HU HU872525A patent/HU199288B/hu not_active IP Right Cessation
- 1987-06-02 DD DD87303436A patent/DD257015A5/de not_active IP Right Cessation
- 1987-06-02 MY MYPI87000752A patent/MY101079A/en unknown
- 1987-06-02 NZ NZ220509A patent/NZ220509A/xx unknown
- 1987-06-02 US US07/056,712 patent/US4919932A/en not_active Expired - Fee Related
- 1987-06-02 EG EG452/87A patent/EG18213A/xx active
- 1987-06-02 FI FI872459A patent/FI872459A/fi not_active Application Discontinuation
- 1987-06-03 ZA ZA873970A patent/ZA873970B/xx unknown
- 1987-06-03 CA CA000538710A patent/CA1294217C/en not_active Expired - Fee Related
- 1987-06-03 NO NO872331A patent/NO872331L/no unknown
- 1987-06-03 PL PL1987266058A patent/PL266058A1/xx unknown
- 1987-06-03 PT PT84996A patent/PT84996B/pt unknown
- 1987-06-03 DK DK284787A patent/DK166759B1/da not_active IP Right Cessation
- 1987-06-03 AU AU73795/87A patent/AU597068B2/en not_active Ceased
- 1987-06-04 CN CN198787104023A patent/CN87104023A/zh active Pending
- 1987-06-04 IL IL82767A patent/IL82767A/xx not_active IP Right Cessation
- 1987-06-04 OA OA59134A patent/OA08609A/xx unknown
- 1987-06-04 JP JP62140717A patent/JPS62292721A/ja active Pending
- 1987-06-04 TN TNTNSN87077A patent/TNSN87077A1/fr unknown
-
1992
- 1992-02-20 GR GR920400271T patent/GR3003856T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sykes et al. | The new monobactams: chemistry and biology | |
| KR101850265B1 (ko) | 항균제 및 타조박탐을 포함하는 조성물 | |
| JPS62292721A (ja) | 細菌感染症治療剤 | |
| AU677235B2 (en) | Crystalline carbapenem derivative | |
| JPS61293988A (ja) | 抗菌作用を有する化合物、その製法およびそれを含有する医薬 | |
| TW202123945A (zh) | 具有抗菌作用的醫藥組成物 | |
| KR20160126004A (ko) | 항세균제를 포함하는 제약학적 조성물 | |
| JP3489635B2 (ja) | 海綿由来活性物質 | |
| JPH02104528A (ja) | 抗菌用組成物 | |
| GB2045746A (en) | 6-(azacycloalky-or azabicycloalkyl-methylimino)penicillanic acid esters | |
| Tomatsu et al. | In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232, and its prodrug esters | |
| GB1562902A (en) | Pharmaceutical compositions containing clavulanic acid | |
| US6242437B1 (en) | Cephem derivatives | |
| JPS6121203B2 (pt) | ||
| US4898731A (en) | Antibiotic combinations of penicillins | |
| US4203972A (en) | Penicillin composition | |
| CN117860759A (zh) | 一种杂环化合物在抗脓肿分枝杆菌中的应用 | |
| Benner et al. | Cephazolin: a comparison to ampicillin in respiratory and urinary infections with dosage regulation by a nomogram | |
| Klesel et al. | RU 29 246, THE ACTIVE COMPOUND OF THE CEPHALOSPORIN PRODRUG-ESTER HR 916 III. PHARMACOKINETIC PROPERTIES AND ANTIBACTERIAL ACTIVITY IN VIVO | |
| DE2760482C2 (de) | Pharmazeutische Zubereitungen, enthaltend ein 7-[2-(2-aminothiazol-4yl)-2-(syn)-methoxyiminoacetamido]cephalosporinderivat | |
| JPS62255426A (ja) | 抗菌性組成物 | |
| AT405180B (de) | Neue derivate von substituierten 3-cephem-4-carbonsäurederivaten und verfahren zu deren herstellung | |
| AT359195B (de) | Verfahren zur herstellung von neuen cephalos- porinverbindungen und deren pharmazeutisch anwendbaren salzen | |
| WO2018193368A1 (en) | Antibacterial compositions | |
| JPS6250448B2 (pt) |